Final results of ProGem1, the first in-human phase I/II study of NUC-1031 in patients with solid malignancies.

View/Open

Accepted version (15.06Kb)

Volume

33

DOI

10.1200/jco.2015.33.15_suppl.2514

Issue

15

ISSN

0732-183X

Metadata

Show full item record

Authors

Blagden, SP; Rizzuto, I; Stavraka, C; O'Shea, D; Suppiah, P; Patel, M; Sukumaran, A; Loyse, N; Bharwani, N; Rockall, A

URI

http://meeting.ascopubs.org/cgi/content/short/33/15_suppl/2514
http://qmro.qmul.ac.uk/xmlui/handle/123456789/12316

Collections

Centre for Haemato-Oncology [167]

Copyright statements

© 2015 American Society of Clinical Oncology